(Q43775712)

26 November 2017

title

Increased risk of recurrence after hormone replacement therapy in breast cancer survivors (English)

1 reference

Hormone Replacement Therapy

26 November 2017

main subject

1 reference

Rodrigo Arriagada

11

0 references

Jacek Jassem

7

object named as

Jacek Jassem

1 reference

26 November 2017

1

Lars Holmberg

1 reference

26 November 2017

6

Janusz Jaskiewicz

1 reference

26 November 2017

Ole-Erik Iversen

2

1 reference

26 November 2017

Carl Magnus Rudenstam

3

1 reference

26 November 2017

Mats Hammar

4

1 reference

26 November 2017

Eero Kumpulainen

5

1 reference

26 November 2017

Daria Dobaczewska

8

1 reference

26 November 2017

Hans E Fjosne

9

1 reference

26 November 2017

Octavio Peralta

10

1 reference

26 November 2017

Marit Holmqvist

12

1 reference

26 November 2017

Johanna Maenpaa

13

1 reference

26 November 2017

HABITS Study Group

14

1 reference

26 November 2017

language of work or name

English

0 references

publication date

25 March 2008

1 reference

Journal of the National Cancer Institute

26 November 2017

published in

1 reference

26 November 2017

volume

100

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

475-482

1 reference

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Menopausal hormone therapy after breast cancer: the Stockholm randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Estrogen replacement therapy in breast cancer survivors: a matched-controlled series

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Breast cancer survival and hormone replacement therapy: a cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

Hormone replacement therapy and risk of breast cancer: the role of progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN058

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJN058

1 reference

26 November 2017

1 reference